What Gossamer Bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,504,500 |
| Disposed | 0 | 0 |
| Net activity | +0 | +1,504,500 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Peterson Caryn | EVP, Regulatory Affairs | Jan 02 | Grant / award · A | +84,500 | — | — | 259,333 |
| Christian Waage | EVP, Tech Ops and Admin | Jan 02 | Grant / award · A | +84,500 | — | — | 814,061 |
| Smith Robert Paul Jr | Chief Commercial Officer | Jan 02 | Grant / award · A | +93,750 | — | — | 260,898 |
| Giraudo Bryan | COO/CFO | Jan 02 | Grant / award · A | +115,750 | — | — | 389,737 |
| Hasnain Faheem | President & CEO | Jan 02 | Grant / award · A | +280,000 | — | — | 837,793 |
| Aranda Richard | Chief Medical Officer | Jan 02 | Grant / award · A | +93,750 | — | — | 463,106 |
| Giraudo Bryan | COO/CFO | Oct 01 | Grant / award · A | +181,250 | — | — | 273,987 |
| Peterson Caryn | EVP, Regulatory Affairs | Oct 01 | Grant / award · A | +125,000 | — | — | 174,833 |
| Hasnain Faheem | President & CEO | Oct 01 | Grant / award · A | +437,500 | — | — | 557,793 |
| Christian Waage | EVP, Tech Ops and Admin | Oct 01 | Grant / award · A | +125,000 | — | — | 710,934 |
| Smith Robert Paul Jr | Chief Commercial Officer | Oct 01 | Grant / award · A | +162,500 | — | — | 162,500 |
| Aranda Richard | Chief Medical Officer | Oct 01 | Grant / award · A | +162,500 | — | — | 369,356 |
| Milligan Sandra | Director | Aug 19 | Open-market buy · P | +26,050 | $1.92 | +$50K | 58,050 |
| Aranda Richard | Chief Medical Officer | Jun 24 | Sale for tax withholding · S | −1,908 | $0.66 | −$1.26K | 196,891 |
| Hasnain Faheem | President & CEO | Jun 21 | Open-market buy · P | +372,000 | $0.67 | +$250K | 5,408,073 |
| Giraudo Bryan | COO/CFO | Jun 18 | Open-market buy · P | +100,000 | $0.59 | +$59.1K | 480,010 |
| Smith Robert Paul Jr | Chief Commercial Officer | Jun 17 | Open-market buy · P | +25,000 | $0.60 | +$15.1K | 25,000 |
| Giraudo Bryan | COO/CFO | Mar 27 | Sale for tax withholding · S | −6,430 | $1.16 | −$7.43K | 92,737 |
| Hasnain Faheem | President & CEO | Mar 27 | Sale for tax withholding · S | −23,172 | $1.16 | −$26.8K | 120,293 |
| Christian Waage | EVP, Tech Ops and Admin | Mar 27 | Sale for tax withholding · S | −6,430 | $1.16 | −$7.43K | 585,934 |
Loading...
